Celldex Therapeutics CLDX
NASDAQ CLDX
$30.65 -0.59 (-1.89%)
At close: Nov 10, 2026 · 4:00 PM EST

Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2013)

Updated

Analysis

Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 217.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 435.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 269.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Celldex Therapeutics 2.47 Bn 131.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 85,000.00
Sep 30, 2013 13,000.00
Jun 30, 2013 519,000.00
Mar 31, 2013 310,000.00
Dec 31, 2012 351,000.00
Sep 30, 2012 381,000.00
Jun 30, 2012 411,000.00
Mar 31, 2012 433,000.00
Dec 31, 2011 438,000.00
Sep 30, 2011 438,000.00
Jun 30, 2011 434,000.00
Mar 31, 2011 485,000.00
Dec 31, 2010 335,000.00
Sep 30, 2010 332,000.00
Jun 30, 2010 334,000.00
API Access

Celldex Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEY